Method for administration of azauridine and pyridoxine for the treatment of rheumatoid arthritis
US5389617A · kind A · utility
3Cited by
0References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 12, 1993 |
| Grant date | Feb 14, 1995 |
| Priority date | — |
| Expiry date | Nov 12, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating patients with rheumatoid arthritis comprises administering azaribine to the patient at a dosage level of 10 to 50 mg/kg/day for an initial period of from about 1 to about 3 weeks and then administering azaribine to the patient at dosage levels of at least 50 mg/kg/day and preferably at least 100 mg/kg/day.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.